Neurimmune AG Employee Directory
Pharmaceutical ManufacturingZurich, Switzerland51-200 Employees
Neurimmune AG is a Swiss biopharmaceutical company in the clinical development phase, pursuing antibody-based therapies. It centers its work on removing amyloid deposits as a therapeutic approach to CNS and related protein-aggregation diseases, including Alzheimer's disease, amyotrophic lateral sclerosis, and ATTR cardiomyopathy. Based in Schlieren, in the Zurich region of Switzerland, the firm operates within pharmaceutical development and translational research for antibody therapies. Its programs target patients and clinicians addressing neurodegenerative and cardiac amyloidoses, with attention to therapies that may modify disease pathways. Recent developments include expanding its collaboration with Alexion to develop NI009 for AL amyloidosis and joining the ACCESS-AD consortium to support timely and equitable Alzheimer's disease diagnosis, treatment, and care.
1-888-653-2347 
support@leadiq.com 
